Live feed
Filing
SC 13G
SC 13G0001422848-24-000355·Capital Research Global Investors
Schedule 13G ownership disclosure
Denali Therapeutics Inc
Security class unavailable · CUSIP: 24823R105
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,909,114
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-24-000355
- Form type
- SC 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Nov 12, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership